Please login to the form below

cancer

This page shows the latest cancer news and features for those working in and with pharma, biotech and healthcare.

Pierre Fabre’s Braftovi scores NICE backing for BRAF+ colorectal cancer

The result underscores our commitment to the colorectal cancer community and we hope that as many people as possible will benefit from this innovative treatment,” she added. ... Over 42, 000 people in the UK are newly diagnosed with colorectal cancer

Latest news

UPDATED: BMS completes $13.1bn acquisition of MyoKardia

This includes the company’s oral anticoagulant Eliquis (apixaban), BMS’ second biggest product after cancer immunotherapy Opdivo (nivolumab).
Moderna posts encouraging early data for personalised cancer vaccine

The vaccine, mRNA-4157, is being evaluated in combination with Merck &Co’s PD-1 inhibitor Keytruda (pembrolizumab) in different cancer types. ... But, we also have a strong signal to point us to study this further in head and neck cancer.
Merck, Eisai’s Keytruda plus Lenvima combo hits the mark in renal cancer

advanced renal cell carcinoma (a form of kidney cancer).
AZ’s BTK inhibitor Calquence fails in COVID-19 study

Therapy is already approved to treat a number of blood cancers. ... Calquence is approved to treat a number of blood cancers and is indicated for use in adults with previously treated mantle cell lymphoma (MCL) as well as adults with chronic lymphocytic
Sanofi set to acquire Kiadis for €308m

Sanofi will provide resources and capabilities to advance the development of Kiadis’ current research programmes for the treatment of blood tumours, solid cancers and infectious disease – which includes the COVID-19

More from news
Approximately 693 fully matching, plus 3,102 partially matching documents found.

Latest Intelligence

Rethinking our approach to infectious disease preparedness

There is a clear pathway to reimbursement, with the metrics for paying for cancer treatments well understood.
The human connection: how to achieve emotive creativity in pharma

your patients a disservice while you’re at it). We’ve been acutely aware of this balancing act in our own work; a recent film we worked on for prostate cancer ... With this as our starting point, we introduced messaging about the importance of
What Hemingway got right about patient communications

about. Digital care for cancer patients. It’s not just a pharma phenomenon: there has also been a huge digital pivot in how our health charity clients now offer care services. ... Similarly, CLIC Sargent – the UK’s leading charity for children and
COVID-19 – a catalyst for technology adoption in clinical trials

The COVID-19 crisis has disrupted clinical trials around the globe, many of which are investigating treatments for life-threatening diseases such as cancer.
BiTE* platform and the evolution toward off-the-shelf immuno-oncology approaches

Amgen Oncology, one of the leading developers of innovative therapies for novel targets in difficult-to-treat cancers, is working to bring new hope for transforming clinical outcomes for patients with ... T cells only become activated and proliferate,

More from intelligence
Approximately 8 fully matching, plus 323 partially matching documents found.

Latest appointments

Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm

newly-diagnosed non-small cell lung cancer (NSCLC) patients.
McCann Health France strengthens team with two new hires

Prior to McCann Health France, she served as scientific director at various international health organisations, including the ARC Foundation for Cancer Research and the French National Cancer Institute.
Genmab hires first chief operating officer

Anthony shares our determination to bring truly differentiated new cancer treatments to the market that will deliver on our commitment to improve patients’ lives while fostering a culture of excellence and
New hires at Crescendo, Healx and Galecto

Galecto. Galecto, a clinical stage company developing treatments for fibrosis and cancer, has appointed Bertil Lindmark as its new chief medical officer.
Ex-Roche CMO Sandra Horning joins Gilead’s board of directors

Horning received her MD from University of Iowa School of Medicine, and completed her post-graduate fellowship in Oncology and Cancer Biology at Stanford University. ... In addition, she brings the perspective of a leading physician who has spent more

More from appointments
Approximately 5 fully matching, plus 208 partially matching documents found.

Latest from PMHub

Great creative is effective creative. And effective creative is affective creative

Melanoma haunts outdoor, in-the-sun Australians. It’s the most lethal cancer for those between 15 and 30.
Mednet Group’s growth spurt

in cancer biology and she has experience working as a research technician in the field of malignant haematology. .
The impact of COVID-19 on cancer care

Cancer screening. The NHS offers bowel, breast and cervical cancer screening programmes to identify individuals at high risk of these cancers and to enable early diagnosis and treatment for those affected. ... that the diagnosis and management of
The other side of … blood cancer

The other side of … blood cancer. “I’m so sick of chasing him down the hospital corridors. ... The environment is certainly one challenge – busy hospital, many blood cancer patients, so her doctor’s time is limited.
Healthcare in a lockdown

Feelings ranged from “[the] NHS have forgotten us and are only concerned with COVID” to “a friend of mine was denied cancer surgery… yeah let’s clap the NHS”. While one